Flabouris A, Myburgh J
Intensive Care Unit, Royal Adelaide Hospital, Australia.
Chest. 1999 Mar;115(3):811-7. doi: 10.1378/chest.115.3.811.
To determine the diagnostic yield, morbidity, mortality, and therapeutic impact of the open lung biopsy in patients requiring mechanical ventilation.
Retrospective review of patient records.
Tertiary ICU.
Patients with respiratory failure and diffuse pulmonary infiltrates requiring mechanical ventilation, leading up to or following an open lung biopsy.
Information included patient demographics, organ failure, microbiological results before open-lung biopsy, Pao,/fraction of inspired oxygen values before and after biopsy, immunosuppression, timing of open lung biopsy, biopsy-related morbidity and mortality, duration of after-biopsy ventilation, open lung biopsy results, biopsy-initiated treatment alterations, and hospital outcome.
Twenty-four patients were identified. The mean age was 48.9 years (confidence interval, 42.1 to 55.7). Twenty-one percent had respiratory infections diagnosed before open lung biopsy but not confirmed by open lung biopsy. Intraoperative complications occurred in 21% of patients, and postoperative complications occurred in 17% of patients. Operative mortality was 8.4%. The specific and the nonspecific diagnostic rates were both 46%. Lung histology was normal in two patients; one of those patients had a false-negative finding. No patient with respiratory failure plus 2 2 other organ failures survived. Alteration of therapy did not differentiate between survivors. Open lung biopsy-guided alteration of therapy directly benefited 39%, and withdrawal was possible in 8.4% of the patients.
The multiple organ dysfunction score should be considered when deciding the relative risk of performing an open lung biopsy, which in this group of patients provided a specific diagnosis in 46% and carried a mortality rate of 8.4%.
确定开胸肺活检对需要机械通气的患者的诊断率、发病率、死亡率及治疗影响。
对患者记录进行回顾性分析。
三级重症监护病房。
呼吸衰竭且有弥漫性肺部浸润需要机械通气的患者,在开胸肺活检之前或之后。
信息包括患者人口统计学资料、器官功能衰竭情况、开胸肺活检前的微生物学结果、活检前后的动脉血氧分压/吸入氧分数值、免疫抑制情况、开胸肺活检的时间、活检相关的发病率和死亡率、活检后通气时间、开胸肺活检结果、因活检而进行的治疗调整以及住院结局。
共纳入24例患者。平均年龄为48.9岁(置信区间为42.1至55.7)。21%的患者在开胸肺活检前被诊断为呼吸道感染,但未得到开胸肺活检的证实。21%的患者发生术中并发症,17%的患者发生术后并发症。手术死亡率为8.4%。特异性和非特异性诊断率均为46%。两名患者的肺组织学正常,其中一名患者有假阴性结果。没有呼吸衰竭合并另外两个器官功能衰竭的患者存活。治疗调整在幸存者中无差异。开胸肺活检指导下的治疗调整使39%的患者直接受益,8.4%的患者可以停止治疗。
在决定进行开胸肺活检的相对风险时应考虑多器官功能障碍评分,在这组患者中,开胸肺活检的特异性诊断率为46%,死亡率为8.4%。